Part,  Chapter, Paragraph

  1    I,     2.  3    |    voluntary pregnancy termination shows that abortion rates are
  2    I,     2.  4    |         available evidence clearly shows that these changes in mortality
  3    I,     2.  5    |          since the 80s. Figure 2.3 shows the significant differences
  4    I,     2.  5    |      forecast compiled by Eurostat shows that the number of older
  5    I,     2.  6    |         countries.~ ~The indicator shows the percentage of the adult
  6    I,     2. 10.  1|        genomic risk stratification shows outcomes which lead to the
  7    I,     3.  1    |           birth cohort perspective shows that women born at the end
  8    I,     3.  1    |          Toulemon, 1995). Research shows that having a partner or
  9    I,     3.  3    |           EU Member States (NMS12) shows two bulges: those born just
 10    I,     3.  3    |            in ageing. Figure 3.5.3 shows the percentage of the population
 11    I,     3.  3    |           of countries only Sweden shows an atypical trend, having
 12    I,     3.  3    |            the smallest. Figure 15 shows that currently Turkey, Ireland,
 13   II,     4.  1    |           countries.~ ~Table 4.1.1 shows estimates for 2005 at European
 14   II,     4.  1    |           at 50 and at 65. It also shows the difference in these
 15   II,     4.  1    |       Michel, 2004).~ ~Table 4.1.3 shows 10-year trends in life expectancy
 16   II,     4.  1    |           per gender~ ~Table 4.1.5 shows firstly that by 2005 LE
 17   II,     4.  1    |         Japan. Secondly, the table shows that gender gaps range from
 18   II,     4.  2    |            7 years).~ ~Table 4.2.1 shows the contribution of age
 19   II,     4.  2    |       causes of death. Table 4.2.2 shows the contribution of 13 selected
 20   II,     4.  2    |         remaining causes of deathshows. In the 1980s, the contribution
 21   II,     4.  2    |        EU15 average.~ ~Table 4.2.3 shows the Arriaga decomposition
 22   II,     4.  2    |            diseases.~ ~Table 4.2.4 shows by how many years life expectancy
 23   II,     4.  2    |     expectancy at birth. The table shows that for men in 7 out of
 24   II,     4.  2    |            countries~ ~Table 4.2.5 shows that cancers caused by smoking
 25   II,     4.  2    |            recent decades, table 6 shows the average change in life
 26   II,     4.  2    |           countries.~ ~Table 4.2.6 shows that in 11 out of the 17
 27   II,     4.  2    |           for women.~ ~Table 4.2.7 shows the development of mortality
 28   II,     5.  1.  1|    diseases~The available evidence shows that important risk factors
 29   II,     5.  1.  2|          heterogeneous reality. It shows how difficult it is to define
 30   II,     5.  2.  3|            Morbidity~ ~Table 5.2.2 shows IHD and AMI hospital discharge
 31   II,     5.  2.  3|       Morbidity~ ~Table 5.2.2 also shows stroke hospital discharge
 32   II,     5.  2.  4|             160 mmHg).~Table 5.2.8 shows data on total cholesterol:
 33   II,     5.  3.  1|      health relevance. Table 5.3.1 shows the burden of these cancer
 34   II,     5.  3.  5|      implementation.~Figure 5.3.17 shows that the maximum incidence
 35   II,     5.  3.  5|            with GDP.~Figure 5.3.19 shows that in 2007 mortality rates
 36   II,     5.  4.  3|             Standardised incidence shows a ten-fold variation, ranging
 37   II,     5.  4.  4|       prevalence results. Evidence shows that prevalence is rapidly
 38   II,     5.  5.  3|           loss of nervous originsshows beside an avoidance of highly-caloric
 39   II,     5.  5.  3|            2024-year-old females) shows an incidence rate of 81,
 40   II,     5.  5.  3|        year follow-up for Goteborg shows that 50% of anorectic persons
 41   II,     5.  5.  3|       episode, an additional third shows a chronic progressive course,
 42   II,     5.  5.  3|          prescribing practice also shows significant differences
 43   II,     5.  5.  3|            is unknown. The disease shows heterogeneity with respect
 44   II,     5.  5.  3|          The clinical course of MS shows heterogeneity among patients
 45   II,     5.  9.  4|     species. Moreover, this report shows that sensitization to Olea
 46   II,     5. 10.  1|        identified foods causing FA shows a geographical variation
 47   II,     5. 11.  3|         Atopic eczema in childhood shows a striking social class
 48   II,     5. 12.  3|           mortality from cirrhosis shows a general favourable trend
 49   II,     5. 13    |      Moreover, a systematic review shows that childhood obesity is
 50   II,     5. 14.  3|        also high in children. This shows that significant proportions
 51   II,     5. 14.  4|       Currently available evidence shows that important risk factors
 52   II,     5. 15.  3|          treated etc.). The survey shows that access differs between
 53   II,     6.  3.  1|       chapters in this report also shows that across the EU there
 54   II,     6.  3.  2|        across and within countries shows a lot of variation. Furthermore,
 55   II,     6.  3.  2|         for AMR, antimicrobial use shows a general gradient from
 56   II,     6.  3.  3|            and Slovakia (Lithuania shows a stable trend). In 2005,
 57   II,     6.  3.  6|            five years. The disease shows a characteristic seasonality
 58   II,     7.  3.  2|         falls in the elderly. This shows that further efforts are
 59   II,     7.  3.  4|     non-fatal work place accidents shows a significant variation
 60   II,     7.  3.  4|   accidents by severity, EU15 + NO shows the severity of non-fatal
 61   II,     7.  4    |           previous chapter clearly shows the public health relevance
 62   II,     9        |            ESPAD from 16 year olds shows a range of persons who had
 63   II,     9.  1.  2|          Denmark).~ ~Table 9.1.2.3 shows TOPFA before and after 20
 64   II,     9.  1.  2|          Chapter 8. Figure 9.1.2.2 shows the resulting increase in
 65   II,     9.  1.  2|  requirement in theory, experience shows that while parental refusals
 66   II,     9.  2.  2|           to promote breastfeeding shows a far from perfect picture
 67   II,     9.  2.  3|           summary of the situation shows that we do not know well
 68   II,     9.  2.  3|          11-15 years of age group, shows that by no means all children
 69   II,     9.  2.  4|            ESPAD from 16 year olds shows a range of persons who had
 70   II,     9.  3.  1|         percent of cervical cancer shows evidence of HPV infection (
 71   II,     9.  3.  2|           Delivery~Figure 9.3.2.3. shows an increasing trend towards
 72   II,     9.  3.  3|     health promotion, but evidence shows that they need to go beyond
 73   II,     9.  4.  3|         aged 0-14 years [per 100]) shows that Italy is the ‘oldest’
 74  III,    10.  1    |           society.~ ~Figure 10.1.2 shows another model of some of
 75  III,    10.  2.  1|     improvement. Economic evidence shows that tobacco control interventions
 76  III,    10.  2.  1|           heart disease.~ ~Alcohol shows reproductive toxicity. Prenatal
 77  III,    10.  2.  1|            extensive evidence that shows the effectiveness and cost-effectiveness
 78  III,    10.  2.  1|          Wilbourne 2002). Evidence shows that individuals exposed
 79  III,    10.  2.  1|        year use of different drugs shows that more than 10% of Europeans
 80  III,    10.  2.  1|         Data from the ESPAD survey shows an overall increase in the
 81  III,    10.  2.  1|          HIV prevalence among IDUs shows considerable variation in
 82  III,    10.  2.  1|        high level. Figure 10.2.3.7 shows the trend in drug-related
 83  III,    10.  2.  1|             Euromonitor's research shows that whitening, sensitive,
 84  III,    10.  2.  1|           Epidemiological research shows that physical inactivity
 85  III,    10.  2.  1|            The Swiss Health Survey shows that the proportion of people
 86  III,    10.  2.  1|          highlights this issue and shows that the amount of physical
 87  III,    10.  2.  1|      Moreover, a systematic review shows that childhood obesity is
 88  III,    10.  2.  1|        weight.~ ~Figure 10.2.1.7.2 shows the prevalence of pre-obesity
 89  III,    10.  2.  1|    respectively. Figure 10.2.1.7.5 shows the gross human apparent
 90  III,    10.  2.  4|        genomic risk stratification shows outcomes which lead to the
 91  III,    10.  3.  1|          for long, recent research shows that the health impacts
 92  III,    10.  3.  2|         and 30 per year (EU15) and shows no clear trend. According
 93  III,    10.  3.  2|       tributaries~ ~Table 10.3.2.2 shows levels of platinum group
 94  III,    10.  3.  2|      different populations clearly shows an increased body burden
 95  III,    10.  3.  2|      different populations clearly shows an increased body burden
 96  III,    10.  3.  2|      summarized in Figure 10.3.2.4 shows decreasing levels of DDT,
 97  III,    10.  3.  3|          and low baseline figures, shows that a general increase
 98  III,    10.  3.  4|         2005. The case of Bulgaria shows that floods threaten the
 99  III,    10.  4.  1|   available year); Figure 10.4.1.2 shows the changes in exposure
100  III,    10.  4.  3|        selected European countries shows there were 90 water-borne
101  III,    10.  4.  5|            Nonetheless, experience shows that successful prevention
102  III,    10.  5.  1|           Urban Audit of EU cities shows that in average, only half (
103  III,    10.  5.  1|          on coal burning in Dublin shows: after the 1990 ban on coal
104  III,    10.  5.  1|      problem for national data and shows what variation in the quality
105  III,    10.  5.  1|        than by income, and thereby shows that even if we analyse
106  III,    10.  5.  2|           the EU countries covered shows a clear difference between
107  III,    10.  5.  2|  Netherlands, the urban population shows more health problems, a
108  III,    10.  5.  2|          et al., 2006). A UK-study shows the same result for birth weight,
109  III,    10.  5.  3|      forecast compiled by Eurostat shows that the number of older
110  III,    10.  6.  1|          Carelia region in Finland shows that individuals with poor
111  III,    10.  6.  1|            the EU~ ~The HBSC study shows the importance of new media
112  III,    10.  6.  2|         available evidence clearly shows that these changes in mortality
113  III,    10.  6.  3|         offences. Figure 10.6.3.1. shows the results. Some countries,
114  III,    10.  6.  3|        below 2%). Figure 10.6.3.1. shows national rates.~ ~Figure
115   IV,    11.  1.  5|          variations in quality and shows that improving quality is
116   IV,    11.  1.  5|        Recent evidence from the US shows that some purchasers are
117   IV,    11.  1.  5| Observational evidence from the US shows that those states with public
118   IV,    11.  1.  6|    negative incentives. Table 11.3 shows the physician payment methods
119   IV,    11.  3.  2|      through centralised procedure shows stability in the main therapeutic
120   IV,    11.  5.  3|           guidelines.~Figure 11.15 shows the different factors included
121   IV,    11.  5.  3|           guidelines. Figure 11.16 shows the biological tests used
122   IV,    11.  5.  3|       transplant~ ~As Figure 11.16 shows, there is consensus in the
123   IV,    11.  5.  3|           evaluation, Figure 11.17 shows the different practices
124   IV,    11.  5.  3|           countries~ ~Figure 11.18 shows the different procedures
125   IV,    11.  5.  4|       Comparison between countries shows that final national donation
126   IV,    11.  5.  5|            Goldman and Wood, 2007) shows the current situation of
127   IV,    11.  6.  1|          the last 10 years clearly shows the consistent growth across
128   IV,    11.  6.  2|           expenditure. Table 11.11 shows that the public share (%)
129   IV,    11.  6.  2|            Eastern European region shows a more consistent decreasing
130   IV,    11.  6.  2|           review of the literature shows cost sharing for prescription
131   IV,    12.  2    |            extensive evidence that shows the effectiveness and cost-effectiveness
132   IV,    12.  2    |      Wilbourne 2002). The evidence shows that individuals exposed
133   IV,    13.  2.  3|           diseases. The comparison shows that the overall health
134   IV,    13.  2.  3|        depression. Table 13.7 also shows that the demonstrable health